This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
LOG Pharma Primary Packaging is set to present its new barrier eco line at Pharmapack Europe 2025. LOGs barrier packaging solutions are designed to prolong shelf life and protect innovative and generic drugs from the exposure to moisture and/or oxygen, the company explained on its website.
With the Indian pharma market projected to grow to $ 130 billion by 2030 and $ 450 billion by 2047, the event highlighted the industry’s vital role in shaping global healthcare. Projections indicate exports will soar to $130 billion by 2030 and $450 billion by 2047. trillion.
In 2024, Pharmapack Europe, the two-day exhibition and conference for pharma’s drug delivery and packaging industry will introduce two brand new zones to the flagship event. Bio packaging zone . Pharmapack’s bio packaging zone builds on its long history of being at the forefront of innovations in biological drug delivery.
The company focuses on utilising packaging to minimise end-of-life waste and employs distribution methods that further reduce environmental impact. We have committed to reduce our scope 1 and 2 GHG emissions by 42 per cent (absolute) by the end of 2030 (from a 2021 basis).
We also see a growing emphasis on sustainable practices in manufacturing and packaging, aligning with global trends in reducing carbon footprint and waste. In addition, the nutra market boom in APAC that began during the COVID-19 pandemic continues to accelerate looking for green-label, plant-based capsules for encapsulation.
With a Rs 2,143 crore allocation under the Production Linked Incentive (PLI) scheme, India is set to lead globally in pharmaceuticals, with the domestic market projected to reach $ 130 billion by 2030. These steps are vital for achieving our $5 trillion GDP goal in three years and $7 trillion by 2030.
It provides an unparalleled platform for stakeholders to participate in extensive dialogues covering pharma machinery, packaging, analytical instruments, laboratory technologies, equipment, ancillaries, ingredients, and beyond. Despite challenges in CIS countries, the global reception of Indian pharma remains positive.
The Indian pharma industry is on a solid growth trajectory, surging from $40 billion in 2021 to an estimated $130 billion in 2030, with a steady double-digit CAGR for the next 10 years. In addition to meeting strong domestic demand, the Indian pharmaceutical industry is well poised as a robust contributor to the growing global market.
As per the statistics provided by Invest India, the industry is expected to reach a whopping $130 billion market by 2030. The technology makes use of desiccant dehumidifiers to constantly maintain RH as low as 1 per cent or even lower during the production, processing, storage, and packaging of the products.
Employees achieved a 98 per cent completion rateof the compliance training, including ESG modules Other initiatives include a 2030 target being established for Pharmanovia’s transition to an electric hybrid vehicle fleet, while technology is also being embraced to strengthen the company’s supply chain policy.
Lilly’s 30×30 initiative aims to improve access to quality healthcare for 30 million people living in limited-resource settings, annually, by 2030. Mikkelsen added that “the hope is to have insulin and diabetes devices as part of Essential Benefit Packages in low- and middle-income countries towards achieving Universal Health Coverage.”
Fette Compacting Machinery India, Ace Technologies & Packaging Systems, DPB Antibiotics, Lee Pharma, Omniscient Health, hcare, Venkata Narayana Active Ingredients, Unilab Chemicals and Pharmaceuticals, and many others. A vaccine manufacturing powerhouse, India leads by supplying over 60 per cent of global vaccine demand.
It is already a massive $50 billion market and is projected to grow to $130 billion by 2030. India’s pharmaceutical industry is a global powerhouse. India makes 60 per cent of the world’s vaccines and 20 per cent of the world’s generic drugs. The second chink is its climate and environmental footprint.
According to the World Health Organization, the world will need more than 40 million new doctors, nurses, frontline healthcare workers, and various other healthcare professionals by 2030. This equates to approximately doubling the current medical workforce. VR for real world education.
He is “confident” in Rayne’s ability to “execute towards our 2030 vision to transform the lives of people with cancer and other serious diseases with knock-your-socks-off (KYSO ® ) antibody medicines”. Previously, Rayne held the role of Chief Operating Officer at Capsida Biotherapeutics.
Biologics product development has increased steadily over the past decade, with the volume of business forecast to double by 2030. The Chiesi Group already has broader commitments to adopt 100% renewable energy and reduce greenhouse gas emissions by 80% before 2030 and by 90% before 2035. The rise of biologics.
Moreover, no attendee data was available for physical symposia, whereas all virtual symposia packages provided full attendee metrics analyses. Accessibility to physical symposia was limited to approximately one hour, compared with three years on-demand for virtual symposia, or 26,280 times longer. Postscript.
It’s a package, and sometimes we deploy one or two modules, sometimes multiple modules in a project. Philips has set a target that by 2030, it wants to improve 400 million lives annually in access to care countries as part of its bigger ambition to improve the lives of 2.5 billion people annually. Accenture and KPMG.
10 Diagnostics and biologics also heavily utilise carbon-based materials as constituting building blocks, processing aids, single-use reactors, or packaging materials. In the context of CO 2 neutrality, the years 2030 and 2050 are mentioned as crucial milestones.
Expanding PEPFAR’s procurement goals There are currently about 600 manufacturers producing packaged medicines in Africa , with 80 percent of those producers concentrated in just eight countries. Similarly, by 2030, it plans to put at least two million patients on first-line antiretroviral (ARV) treatments produced on the continent.
Continued Burnout and Veterinary Staff Shortages Unemployment rates continue to affect the veterinary industry, with estimates that by 2030 there will be a shortage of 15,000 veterinarians , making the demand for more workers increasingly urgent.
Private Equity investors are both interested and invested in the health and weight loss market, including nutrition supplements, lifestyle (diet) companies such as Weight Watchers, packaged food and beverage products that we see in supermarkets and drug chains, and the fitness industry, including fitness centers and products such as Peloton.
million nurses/midwives in the total stock by 2030. This will also expand the scope for private health insurance companies to include them in their products, irrespective of the package cost. . – A recent WHO report estimated a shortage of about 1.8 million health workforces in India and suggests that to meet the threshold of 34.5
The plant is specialised in the purification and filling of plasma-derived therapies, with packaging capabilities for a variety of plasma treatments. We aim to become a net-zero carbon emissions operation by 2030 and have a clear focus on further digitalisation.
According to the report, the packaging segment of the market will be worth $15.6 billion by 2026, as contract manufacturing organisations increasingly adopt newer and efficient ways to package products, increasing demand for new machinery. For instance, efforts are underway to automate packaging of personalised cell and gene therapies.
AGI Greenpac, a packaging products company in India, has received the Indian Green Building Council (IGBC) Platinum rating for its Specialty Glass Plant in Bhongir. These initiatives collectively position AGI Greenpac’s Specialty Glass Plant as a sustainability benchmark in the packaging products industry.
The challenge for pharma in reducing its carbon footprint A recent study presented at COP27 , found that just 4% of biotechnology and pharmaceutical companies were currently on track to meet Paris 2030 climate goals, with the pharmaceutical industry being among the world’s largest carbon emitters.
Kenilworth, NJ, US) is investing $500 million in its Singapore facilities, including setting up a secondary packaging facility and building an inhaler production plant. The BioPIPS project is in line with Singapore’s wider “Manufacturing 2030” program, which aims to boost the country’s manufacturing by 50%.
Digital innovation is a critical piece of the response to this challenge, and as part of our ongoing commitment to the environment, AstraZeneca has begun the transition to electronic product information (ePI) , with the goal of introducing ePI across all products by 2030. billion litres of water could be saved each year.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content